Frequently Asked Questions
KLOW peptides are a proprietary multi-component research blend. The name refers to the first letters of the principal components in the most common industry formulation: Kisspeptin, LL-37, Oxytocin, and the Wolverine Blend (BPC-157 plus TB-500). Velora supplies KLOW as an 80mg lyophilized research compound for in vitro and preclinical investigation only. Verify exact component ratios against the active Certificate of Analysis.
In published preclinical literature, the individual KLOW components have been characterized across hypothalamic-pituitary-gonadal-axis research (Kisspeptin-10), antimicrobial peptide and tissue-remodeling research (LL-37), neuropeptide-signaling research (Oxytocin), and tissue-remodeling and angiogenesis research (Wolverine Blend). The KLOW blend is supplied to support multi-pathway research designs that require all four components in a fixed ratio. Nothing about the blend or its components is claimed to produce any specific outcome in humans, animals, or therapeutic applications.
Velora Research supplies the KLOW peptide blend with per-component HPLC and mass-spec verification. Each Certificate of Analysis is tied to the specific lot number printed on the vial and is downloadable from the product page. Pricing reflects research-grade per-component verification rather than commodity bulk-blend supply.
Each component peptide is independently tested by a third-party analytical laboratory using HPLC for purity and mass spectrometry for identity. The combined Certificate of Analysis covers all four components in the blend and is published on our /coas/ page and linked from this product page by batch number.
Store the lyophilized vial sealed at -20°C in a dry, dark environment. Once reconstituted with bacteriostatic water, refrigerate at 2 to 8°C and use within the stability window established by the research protocol. Avoid repeat freeze-thaw cycles, which can degrade peptide integrity, especially for the smaller components in a multi-peptide blend.
Buy the KLOW peptide blend if your protocol calls for a fixed-ratio combination of Kisspeptin-10, LL-37, Oxytocin, and the Wolverine Blend, or if you are running comparative assays against any individual component. Buy the components separately if your study only requires one or two of the four, or if your protocol requires a custom (non-fixed) ratio. The blend price is set so that a researcher needing all four components saves on per-mg cost versus buying separately.
Velora Research lists the KLOW peptide blend at $120.00 USD per 80mg combined vial (sale pricing periodically available). Free US shipping applies on orders over $200. Pricing reflects research-grade per-component HPLC and mass-spec verification.
No. Velora Research supplies the KLOW peptide blend strictly for laboratory research conducted by qualified institutions and research professionals. The product is not packaged or quality-controlled for personal, cosmetic, wellness, nutritional, or therapeutic use. Purchasers confirm research-use-only intent at checkout.
Velora Research accepts international orders for laboratory research use only. Buyers are responsible for ensuring compliance with all applicable local, state, and national regulations in their jurisdiction prior to purchasing.
⚖️ Compliance & Disclaimer
All products sold by Velora Research are intended solely for scientific research use in laboratory settings. The KLOW peptide blend is supplied for in vitro and preclinical investigation and is not for human or veterinary use, not for food, drug, cosmetic, or therapeutic application. None of the individual peptides in the KLOW blend (Kisspeptin-10, LL-37, Oxytocin, BPC-157, TB-500) is approved by the FDA as a therapeutic compound in the formulation supplied by Velora Research. (Note: Oxytocin acetate is separately FDA-approved as a clinical pharmaceutical under different manufacturers and formulations; Velora’s product is a research compound and is not the clinical product.) By purchasing the KLOW peptide blend, you confirm that you are a qualified researcher or institutional buyer aged 21 or older and accept full responsibility for the safe, legal, and ethical handling of these materials. All sales are final.
Implementation checklist:
- RESOLVE THE FOUR ISSUES IN SECTION 0 BEFORE DEPLOYING THIS REWRITE. Restock or add back-in-stock capture, correct the purity specification, publish a working COA link, and verify the component breakdown matches the active COA. This is non-negotiable.
- Paste short description into WooCommerce Short Description field once the component composition is verified.
- Paste long copy into the Description tab, preserving the H3/H4 heading hierarchy.
- Wrap the FAQ section with FAQPage JSON-LD schema. Q&A pairs must match on-page text exactly.
- Add internal link from the KLOW page’s component-breakdown section to the stand-alone Wolverine Blend (BPC-157 + TB-500) product page for the W component, since Velora already sells that as a separate SKU. This creates internal-link reinforcement between the two related products and helps buyers who want only the recovery component find the right SKU.
- If Velora separately sells Kisspeptin-10, LL-37, or Oxytocin as stand-alone research peptides in the future, link the component descriptions to those product pages. For now, those are component-only references.
- Submit URL for re-indexing via GSC URL Inspection after publishing. Expected outcome given the unrated KDs across the KLOW family: top-3 to top-5 visibility on ‘klow peptides’ and ‘klow blend’ within 6 to 10 weeks of clean deployment.
